
Opinion|Videos|December 21, 2023
Case 2: Male, 35 Years Old
Author(s)Elizabeth Kiracofe, MD, FAAD
Dr. Elizabeth Kiracofe discusses a case of unstable vitiligo in a 35-year-old male, addressing the impact of an outdoor lifestyle on treatment, the efficacy of topical ruxolitinib, and its utility in difficult-to-repigment areas.
Advertisement
Episodes in this series
Dr Elizabeth Kiracofe discusses a case of unstable vitiligo in a 35-year-old male, addressing the impact of an outdoor lifestyle on treatment, the efficacy of topical ruxolitinib, and its utility in difficult-to-repigment areas.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Harrison Nguyen, MD, MBA, MPH’s Deep Dive into CSU, Vasculitis, and Autoimmune Blisters
2
From TikTok to Targeted Therapy: Shannon Trotter, DO, on Modern Dermatology Challenges
3
Day 3 Recap: SDPA Fall 2025
4
Derm Dispatch at SDPA Fall 2025: How a New Initiative Will Transform Dermatologic Health Through Nutrition
5
















